Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Veronica, Höiom"'
Autor:
John Charles A. Lacson, Shawn A. Zamani, Luis Alberto Ribeiro Froes, Nandita Mitra, Lu Qian, Scarlet H. Doyle, Esther Azizi, Claudia Balestrini, D. Timothy Bishop, William Bruno, Blanca Carlos-Ortega, Francisco Cuellar, Anne E. Cust, David E. Elder, Anne-Marie Gerdes, Paola Ghiorzo, Thais C. Grazziotin, Nelleke A. Gruis, Johan Hansson, Marko Hočevar, Veronica Höiom, Elizabeth A. Holland, Christian Ingvar, Gilles Landman, Alejandra Larre-Borges, Graham J. Mann, Montserrat Molgo, Luciana Facure Moredo, Håkan Olsson, Jacoba J. Out-Luiting, Barbara Perić, Dace Pjanova, Susana Puig, Julio Salas-Alanis, Helen Schmid, Karin A. W. Wadt, Julia A. Newton-Bishop, Peter A. Kanetsky, on behalf of the GenoMEL Study Group
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background Individuals from melanoma-prone families have similar or reduced sun-protective behaviors compared to the general population. Studies on trends in sun-related behaviors have been temporally and geographically limited. Methods Indi
Externí odkaz:
https://doaj.org/article/294d462bfbc04eba8673cab873afcf12
Autor:
Yaxuan Liu, Hafdis T. Helgadottir, Pedram Kharaziha, Jungmin Choi, Francesc López-Giráldez, Shrikant M. Mane, Veronica Höiom, Carl Christofer Juhlin, Catharina Larsson, Svetlana Bajalica-Lagercrantz
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1004 (2022)
Breast cancer is the most prevalent malignancy among women worldwide and hereditary breast cancer (HBC) accounts for about 5–10% of the cases. Today, the most recurrent genes known are BRCA1 and BRCA2, accounting for around 25% of familial cases. A
Externí odkaz:
https://doaj.org/article/310fa80fb70a4b9987ee96b7204adc7b
Autor:
Esteban, Astiazaran-Symonds, Cole, Graham, Jung, Kim, Margaret A, Tucker, Christian, Ingvar, Hildur, Helgadottir, Lorenza, Pastorino, Remco, van Doorn, Joshua N, Sampson, Bin, Zhu, William, Bruno, Paola, Queirolo, Giuseppe, Fornarini, Stefania, Sciallero, Brian, Carter, Belynda, Hicks, Amy, Hutchinson, Kristine, Jones, Douglas R, Stewart, Stephen J, Chanock, Neal D, Freedman, Maria Teresa, Landi, Veronica, Höiom, Susana, Puig, Nelleke, Gruis, Xiaohong R, Yang, Paola, Ghiorzo, Alisa M, Goldstein
Publikováno v:
JCO precision oncology. 6
Pancreatic ductal adenocarcinoma (PDAC) is a component of familial melanoma due to germline pathogenic variants (GPVs) inWe analyzed 189 cancer predisposition genes using parametric rare-variant association (RVA) tests and nonparametric permutation t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf016f5a79e62293ca6bfcd6d789bb6a
https://pubmed.ncbi.nlm.nih.gov/36409970
https://pubmed.ncbi.nlm.nih.gov/36409970
Autor:
Brage, Fernanda Costa Svedman, Ishani Das, Rainer Tuominen, Eva Darai Ramqvist, Veronica Höiom, Suzanne Egyhazi
Publikováno v:
Cancers; Volume 14; Issue 15; Pages: 3587
Targeted therapy (TT), together with immune checkpoint inhibitors (ICI), has significantly improved clinical outcomes for patients with advanced cutaneous malignant melanoma (CMM) during the last decade. However, the magnitude and the duration of res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::41f861f5d26015450f28171fd954db65
Autor:
Fernanda, Costa Svedman, Ishani, Das, Rainer, Tuominen, Eva, Darai Ramqvist, Veronica, Höiom, Suzanne, Egyhazi Brage
Publikováno v:
Cancers. 14(15)
Targeted therapy (TT), together with immune checkpoint inhibitors (ICI), has significantly improved clinical outcomes for patients with advanced cutaneous malignant melanoma (CMM) during the last decade. However, the magnitude and the duration of res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0fd15449d4949f9db274f1f79f62a2f
https://pubmed.ncbi.nlm.nih.gov/35892846
https://pubmed.ncbi.nlm.nih.gov/35892846
Autor:
Bajalica-Lagercrantz, Yaxuan Liu, Hafdis T. Helgadottir, Pedram Kharaziha, Jungmin Choi, Francesc López-Giráldez, Shrikant M. Mane, Veronica Höiom, Carl Christofer Juhlin, Catharina Larsson, Svetlana
Publikováno v:
Biomedicines; Volume 10; Issue 5; Pages: 1004
Breast cancer is the most prevalent malignancy among women worldwide and hereditary breast cancer (HBC) accounts for about 5–10% of the cases. Today, the most recurrent genes known are BRCA1 and BRCA2, accounting for around 25% of familial cases. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::a706c76866244484463f9a25ddd38c1a
Autor:
Veronica Höiom, Jan Lapins, Håkan Olsson, Julia Newton-Bishop, Karolin Isaksson, Christian Ingvar, Hildur Helgadottir, Ildikó Fritz
Publikováno v:
JNCI Journal of the National Cancer Institute
Background Over the past decades, many regions have experienced a steady increase in the incidence of cutaneous melanoma. Here, we report on incidence trends for subsequent primary melanoma. Methods In this nationwide population-based study, patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3378caba8c1d9334d7d4fe4267facde5
https://doi.org/10.1093/jnci/djaa088
https://doi.org/10.1093/jnci/djaa088
Autor:
Fernanda Costa Svedman, Marie Jalsenius, Veronica Höiom, Vitali Grozman, Mattias Bergqvist, Fabian Söderdahl, Hanna Eriksson, Samuel Rotstein, Lars Ny, Paolo A. Ascierto, Suzanne Egyhazi Brage, Hildur Helgadottir
Publikováno v:
Cancers; Volume 14; Issue 3; Pages: 702
Cancers, Vol 14, Iss 702, p 702 (2022)
Cancers, Vol 14, Iss 702, p 702 (2022)
Background. Immune checkpoint inhibitors (ICI) are effective in fractions of patients with disseminated melanoma. This study is the first to analyze the plasma activity of thymidine kinase (TK), an enzyme involved in DNA synthesis and repair, as a bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9feffb10a6a12b42b7d582747d44b03d
Autor:
Suzanne Egyhazi Brage, Lena Kanter, Johan Hansson, Hemming Johansson, Veronica Höiom, Johanna Keskitalo, Johan Falkenius
Publikováno v:
Acta oncologica (Stockholm, Sweden). 61(1)
Ulceration is an independent adverse prognostic factor in cutaneous malignant melanoma (CMM). There is, however, a need for additional prognostic markers to identify patients with ulcerated stage I���II CMM who have a high-risk for recurrence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9e292500daf1bb440829f529a98d418
https://pubmed.ncbi.nlm.nih.gov/34694198
https://pubmed.ncbi.nlm.nih.gov/34694198
Autor:
Madeleine Howlie, Tongwu Zhang, Veronica Höiom, Nicholas K. Hayward, Ann-Marie Patch, William Glasson, Lauren M. Bourke, Jane M. Palmer, Elizabeth A. Holland, Antonia L. Pritchard, Peter Johansson, Kevin M. Brown, Graham J. Mann, Karin Wadt, Håkan Olsson, Christian Ingvar, Sunil K Warrier, Göran Jönsson, Judith Symmons, Helen Schmid, Jazlyn Read, Vaishnavi Nathan
Publikováno v:
Melanoma Res
Germline mutations of BRCA1 and BRCA2 predispose individuals to a high risk of breast and ovarian cancer, and elevated risk of other cancers, including those of the pancreas and prostate. BRCA2 mutation carriers may have increased risk of uveal melan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06599686161722528e3ba4c2d2b300c
https://doi.org/10.1097/cmr.0000000000000613
https://doi.org/10.1097/cmr.0000000000000613